Lazard Asset Management’s Core Laboratories CLB Stock Holding History

Lazard Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,775	Closed	-$406K	–	1481
2019 Q2	$406K	Sell	7,775 -466,105	-98%	-$27.3M	﹤0.01%	959
2019 Q1	$32.7M	Buy	473,880 +86,000	+22%	+$5.77M	0.05%	236
2018 Q4	$23.1M	Buy	387,880 +28,000	+8%	+$2.42M	0.04%	267
2018 Q3	$41.7M	Buy	359,880 +40,900	+13%	+$4.61M	0.07%	196
2018 Q2	$40.3M	Buy	318,980 +38,641	+14%	+$4.7M	0.07%	191
2018 Q1	$30.3M	Sell	280,339 -33,700	-11%	-$3.73M	0.05%	241
2017 Q4	$34.4M	Buy	314,039 +21,420	+7%	+$2.14M	0.06%	219
2017 Q3	$28.9M	Sell	292,619 -5,326	-2%	-$516K	0.05%	236
2017 Q2	$30.2M	Buy	297,945 +52,600	+21%	+$5.67M	0.06%	230
2017 Q1	$28.3M	Buy	245,345 +74,799	+44%	+$8.69M	0.05%	237
2016 Q4	$20.5M	Buy	+170,546	New	+$18.9M	0.04%	276
2016 Q2	–	Sell	-355	Closed	-$39K	–	1050
2016 Q1	$39K	Buy	+355	New	+$36.9K	﹤0.01%	880
2015 Q2	–	Sell	-63,300	Closed	-$6.61M	–	1130
2015 Q1	$6.61M	Buy	+63,300	New	+$6.74M	0.01%	478
2014 Q1	–	Sell	-7	Closed	-$1K	–	1017
2013 Q4	$1K	Buy	+7	New	+$1.3K	﹤0.01%	1025

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lazard Asset Management's CLB Position: Q3 2019 in Review

Lazard Asset Management sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 7,775 shares — an estimated $406K sold.

Lazard Asset Management first reported a position in CLB in Q4 2013 and held it in 14 quarters. The position peaked at $41.7M in Q3 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Lazard Asset Management reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Lazard Asset Management sold 7,775 Core Laboratories shares in Q3 2019, an estimated $406K.
Lazard Asset Management first reported a position in Core Laboratories in Q4 2013 and held it in 14 quarters.
Lazard Asset Management's Core Laboratories position peaked at $41.7M in Q3 2018.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.